Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

ACCELERATE DIAGNOSTICS, INC

UEI: H6FFVL332FE4CAGE: 0T3P1

ACCELERATE DIAGNOSTICS, INC is a federal contractor, registered under UEI H6FFVL332FE4 and CAGE code 0T3P1. It has been awarded $4,331,397 in federal contracts. Primary work spans Unknown NAICS, In-Vitro Diagnostic Substance Manufacturing, and Analytical Laboratory Instrument Manufacturing. Top awarding agencies include Department Of Health And Human Services (hhs), Department Of Veterans Affairs, and Department Of Defense (dod).

Contact Information

Registration and classification details

Registration

UEI Code

H6FFVL332FE4

CAGE Code

0T3P1

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325413In-Vitro Diagnostic Substance Manufacturing(Primary)
541714Research and Development in Biotechnology (except Nanobiotechnology)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Accelerate Diagnostics, Inc. specializes in the development and supply of rapid in vitro diagnostic systems and analytical laboratory instrumentation for clinical microbiology, with a focus on identifying pathogens and determining antimicrobial susceptibility directly from positive blood cultures. T...

Accelerate Diagnostics, Inc. specializes in the development and supply of rapid in vitro diagnostic systems and analytical laboratory instrumentation for clinical microbiology, with a focus on identifying pathogens and determining antimicrobial susceptibility directly from positive blood cultures. Their technical expertise centers on molecular diagnostics, phenotypic testing platforms, and integrated reagent kits that enable rapid ID/AST workflows, reducing time-to-result from days to hours. The company’s key differentiator lies in its proprietary platform technology that combines automated sample processing with real-time detection algorithms, supporting high-acuity clinical decision-making in hospital and veterans’ healthcare settings. They also provide maintenance and support services for precision diagnostic equipment, ensuring continuous operational readiness of complex laboratory systems. The Department of Veterans Affairs is the contractor’s primary federal partner, consistently procuring rapid diagnostic systems, test kits, and instrumentation to modernize microbiology laboratories across VA medical centers. Their work supports VA’s mission to improve sepsis outcomes through faster, more accurate pathogen identification and antimicrobial stewardship, with recurring procurements indicating a trusted, long-term relationship built on reliable delivery and clinical validation. The contractor’s industry focus is anchored in in-vitro diagnostic substance manufacturing and analytical laboratory instrument manufacturing, positioning them as a niche supplier within the clinical diagnostics market. They serve the high-compliance, high-reliability segment of hospital and VA laboratories, where speed, accuracy, and regulatory adherence are critical. Their market positioning emphasizes integration of diagnostics with clinical workflows, enabling point-of-care-like speed within central laboratory environments. Accelerate Diagnostics, Inc. is a small business entity headquartered in Tucson, Arizona, with no federal certifications on record. Their government market presence is defined by deep engagement with the VA healthcare system and a focused technical footprint in diagnostic instrumentation and reagent supply, making them a specialized provider for advanced microbiology testing infrastructure.

Key Performance Metrics

Awards Count

40

All time

Active

0

Currently performing

Completed

40

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
Awards by Agency Over Time
Awards by Place of Performance

Compete with ACCELERATE DIAGNOSTICS, INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ACCELERATE DIAGNOSTICS, INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ACCELERATE DIAGNOSTICS, INC's top NAICS codes and agencies

NAICS: 325413
New
DIBBS
CULTURE MEDIUM, THAYER-
Solicitation # SPE2DS-27-T-1066
Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details